It contains all the intermediate substances of the Krebs cycle, such as stimulants and activators of the relative enzymatic functions at a mitochondrial level, eliminating the obstructions generated on entering the lactic acid phase. It has been complemented with the components that help towards the correct development of muscular tissue, ageing and tiredness, cellular revitalisation, muscular stimulant, adinamia and muscular tiredness.

Skin ageing is the result of the action of various intrinsic and extrinsic factors (Uitto J. et al) the most important of which is related to natural, genetically programmed ageing. This process may also be accentuated by various other factors such as the nutritional or hormonal condition (Raine-Fenning N.J. et al), smoking (Yin L. et al), exposure to UV rays (Ma W. et al), mechanical stress (Lapiere C.M.), etc. In all cases, ageing causes both cellular and molecular damages and a disorganisation of the ECM architecture (Baynes J.W.,Scharfetter-Kochanek K. et al, West M.D.,Quaglino D. et al, Yaar M. et al, Meyer L.J. et al, Fornieri C. et al), resulting in a loss of elasticity and tone in the skin which starts to stretch and sag (Sykes J.M.).

The formulation of BIOLIFT has been designed to attenuate the effects of ageing and to combat the consequences of early ageing. Senescence of the fibroblasts causes a drop in the synthesis and maintenance of the ECM, resulting in the disorganisation of the skin. BIOLIFT slows down this process by providing the nutritional elements required for the optimal function and renewal of the fibroblasts.

BIOLIFT also contains dimethylaminoethanol (DMAE), an active ingredient known to increase the firmness of the skin(Uhoda I. et al, Kiss Z. et al), and carnosine, a dipeptide derived from histidine, the anti-ageing activity of which has been widely published in the scientific literature
Supplementary anti-flaccidity therapy in toning treatments, weight loss programmes, optimum maintenance of muscular mass.


The oval of the face is reformed.
Stimulates the contraction of the muscular filaments of the skin with its tensor effect.  It is compatible with the botulinic toxin.
Improves the moisturising of the skin
Captures free radicals and protects from external abrasions.


Biolift has no adverse reactions, contraindications or side effects and it is compatible with any other medicine. Negative in doping.


Base Solution Ampoules
Water, Sodium chloride, Ascorbic acid, Vitamin B1, Vitamin B2, Vitamin B6, Nicotinamide, Magnesium phosphate.

Activator Vials

L-Alanine, L-Carnosine, L-Glutamic Acid, Glycine, LLysine, L-Proline, DMAE, L-Valine, Minerals Salts, Vitamins, Aminoacids.


The box contains n.10 Biolift Base Solution sterile ampoules of 2.0mL e.a. and n.2 Biolift Activator sterile vials of 5.0mL e.a.


Wlaschek M. Photoaging of the skin from phenotype to mechanisms. Exp Gerontol. 2000 May;35(3):307-16 • Meyer LJ, Stern R. Age-dependent changes of hyaluronan in human skin. J Invest Dermatol. 1994 Mar;102(3):385-9 • Fornieri C, Quaglino D Jr, Mori G. Correlations between age and rat dermis modifications. Ultrastructural-morphometric evaluations and lysyl oxidase activity. Aging (Milano). 1989;1(2):127-38 • Sykes JM. Rejuvenation of the aging neck. Facial Plast Surg. 2001 May;17(2):99-107 • Biochim Biophys Acta. 1998 Mar 12;1380(1):1-9 • Uhoda I,Faska N, Robert C, Cauwenbergh G, Pierard GE. Split face study on the cutaneous tensile effect of 2-dimethylaminoethanol (deanol) gel. Skin Res Technol. 2002 Aug;8(3):164-7 • Kiss Z, Crilly KS. Ethanolamine analogues stimulate DNA synthesis by a mechanism not involving phosphatidylethanolamine synthesis. FEBS Lett. 1996 Feb 26;381(1-2):67-70 • Boldyrev AA, Gallant SC, Sukhich GT.Carnosine, the protective, anti-aging peptide.Biosci Rep. 1999 Dec;19(6):581-7 • Quinn PJ, Boldyrev AA, Formazuyk VE.Carnosine: its properties, functions and potential therapeutic applications. Mol Aspects Med. 1992;13(5):379-444 • Nagai K, Suda T, Kawasaki K, Mathuura S.Action of carnosine and beta-alanine on wound healing. Surgery. 1986 Nov;100(5):815-21.